Sign In
Buy GLTO
$22.20
+0 (+0%)
At Close: Jun 18, 2026
Galecto expects to continue dosing patients in the 3 mg arm, whereas the 10 mg arm and combinations with nintedanib or pirfenidone will be discontinued at the recommendation of the DSMB Galecto expect
Galecto to Present at Upcoming Investor Conferences
08:00am, Tuesday, 09'th Feb 2021
BOSTON, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced Hans Schambye,
Galecto Appoints Anne Prener to its Board of Directors
08:00am, Friday, 08'th Jan 2021
BOSTON, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Galecto, Inc., (NASDAQ: GLTO) a NASDAQ listed biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced t
Galecto to Take Part in Two Panel Discussions at the LifeSci Partners 10th Annual Healthcare Corporate Access Event
04:01pm, Monday, 04'th Jan 2021
BOSTON, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a NASDAQ listed biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced th
Galecto Reports Third Quarter 2020 Operating & Financial Results and Provides a Corporate Update
08:06am, Friday, 11'th Dec 2020
Successfully completed listing on US Nasdaq and raised over $ 150 million during recent IPO and preceding crossover round
BOSTON and COPENHAGEN, Denmark, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Galecto, Inc., a NASDAQ listed biotechnology company focused on the development of novel treatments for fibrosis and cancer, announce
Galecto Appoints Experienced Healthcare Executive Jayson Dallas to Board of Directors
04:01pm, Monday, 23'rd Nov 2020
BOSTON and COPENHAGEN, Denmark, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and
U.S. IPO Week Ahead: The IPO Market Takes A Break During The Shortened Holiday Week
12:35pm, Sunday, 22'nd Nov 2020
The IPO market is taking a break during the shortened Thanksgiving week, with just one IPO and two SPACs scheduled to raise $900 million. Russian e-commerce company Ozon Holdings plans to raise $750 m
Galecto Announces Pricing of Initial Public Offering
09:10pm, Wednesday, 28'th Oct 2020
BOSTON and COPENHAGEN, Denmark, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company developing therapeutics that are designed to target the biologica
